Early salvage versus adjuvant therapy for treatment of prostate cancer following prostatectomy
BMJ Evid Based Med
.
2021 Dec;26(6):e8.
doi: 10.1136/bmjebm-2020-111592.
Epub 2020 Dec 24.
Authors
Meera Garriga
1
,
Felix Y Feng
2
,
W Robert Lee
3
,
Julian C Hong
4
5
Affiliations
1
School of Medicine, University of California San Francisco, San Francisco, California, USA.
2
Department of Radiation Oncology, University of California San Francisco, San Francisco, California, USA.
3
Department of Radiation Oncology, Duke University, Durham, North Carolina, USA.
4
Department of Radiation Oncology, University of California San Francisco, San Francisco, California, USA julian.hong@ucsf.edu.
5
Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.
PMID:
33361287
DOI:
10.1136/bmjebm-2020-111592
No abstract available
Keywords:
disease management; evidence-based practice; medical oncology; radiotherapy.
MeSH terms
Humans
Male
Prostatectomy*
Prostatic Neoplasms* / surgery
Salvage Therapy